Xiaodong Cheng Selected Research

Antiviral Agents (Antivirals)

2/2021	Properties of the Novel Chinese Herbal Medicine Formula Qu Du Qiang Fei I Hao Fang Warrant Further Research to Determine Its Clinical Efficacy in COVID-19 Treatment.
1/2021	An Analysis Regarding the Prognostic Significance of MAVS and Its Underlying Biological Mechanism in Ovarian Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaodong Cheng Research Topics

Disease

65	Neoplasms (Cancer) 02/2024 - 07/2004
24	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 02/2007
16	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2023 - 02/2012
13	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2013
11	Carcinogenesis 10/2022 - 01/2007
10	Ovarian Epithelial Carcinoma 01/2023 - 03/2006
9	Infections 01/2023 - 06/2013
9	Inflammation (Inflammations) 04/2020 - 01/2007
6	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2023 - 04/2007
6	Carcinoma (Carcinomatosis) 05/2022 - 02/2007
5	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2005
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 02/2016
4	Mental Disorders (Mental Disorder) 01/2020 - 01/2013
4	Pancreatic Neoplasms (Pancreatic Cancer) 07/2017 - 01/2013
4	Adenocarcinoma 10/2016 - 05/2013
3	Femoral Neck Fractures 12/2023 - 08/2021
3	Hemoglobinopathies 11/2023 - 01/2021
3	Genomic Instability 11/2023 - 08/2014
3	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 01/2023 - 03/2019
3	Melanoma (Melanoma, Malignant) 02/2022 - 07/2013
3	Pain (Aches) 11/2021 - 03/2016
3	Obesity 01/2018 - 02/2014
3	Nervous System Diseases (Neurological Disorders) 12/2017 - 05/2014
3	Heart Failure 12/2017 - 05/2014
2	variable Immunodeficiency syndrome 12/2023 - 01/2019
2	Neuroinflammatory Diseases 12/2023 - 01/2021
2	Thalassemia 11/2023 - 01/2021
2	Sickle Cell Anemia (Hemoglobin S Disease) 11/2023 - 01/2021
2	Hematologic Neoplasms (Hematological Malignancy) 06/2023 - 10/2021
2	Bacterial Infections (Bacterial Infection) 04/2023 - 04/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 10/2021
2	Choriocarcinoma 12/2022 - 01/2022
2	Lymphatic Metastasis 02/2022 - 01/2021
2	Hyperthermia 01/2022 - 07/2021
2	Hypoalbuminemia 01/2022 - 09/2021

Drug/Important Bio-Agent (IBA)

39	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2002
20	erythromycin propionate-N-acetylcysteinateIBA 01/2023 - 12/2007
12	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 02/2014
9	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2014
9	Transcription Factors (Transcription Factor)IBA 11/2023 - 01/2005
9	Messenger RNA (mRNA)IBA 11/2023 - 07/2007
8	ElementsIBA 01/2024 - 04/2015
8	RNA (Ribonucleic Acid)IBA 10/2023 - 12/2018
6	Polysaccharides (Glycans)IBA 12/2023 - 01/2019
6	Paclitaxel (Taxol)FDA LinkGeneric 10/2023 - 01/2014
6	Small Interfering RNA (siRNA)IBA 11/2022 - 02/2007
5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 05/2013
5	3- (5- tert- butylisoxazol- 3- yl)- 2- ((3- chlorophenyl)hydrazono)- 3- oxopropionitrileIBA 05/2018 - 11/2013
4	PlatinumIBA 11/2023 - 01/2017
4	Circular RNAIBA 10/2023 - 10/2019
4	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 08/2018
4	Phosphotransferases (Kinase)IBA 01/2023 - 05/2015
4	AntigensIBA 02/2022 - 01/2014
4	MethyltransferasesIBA 01/2022 - 02/2014
4	Oncogene Proteins (Oncogene Protein)IBA 07/2021 - 08/2010
4	Peptides (Polypeptides)IBA 03/2021 - 01/2007
4	Protein Isoforms (Isoforms)IBA 12/2020 - 08/2008
3	ChromatinIBA 02/2024 - 01/2011
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2023 - 09/2021
3	Azacitidine (5 Azacytidine)FDA Link 06/2023 - 02/2014
3	Decitabine FDA Link 06/2023 - 02/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2023 - 04/2020
3	UbiquitinIBA 01/2023 - 01/2013
3	Long Noncoding RNAIBA 01/2023 - 12/2020
3	Cadherins (E-Cadherin)IBA 01/2023 - 01/2013
3	Caspase 3 (Caspase-3)IBA 01/2023 - 01/2021
3	Histones (Histone)IBA 01/2023 - 01/2018
3	Carrier Proteins (Binding Protein)IBA 01/2022 - 03/2006
3	ArsenicIBA 09/2021 - 07/2012
3	Therapeutic UsesIBA 09/2021 - 01/2019
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2014
3	LipidsIBA 01/2021 - 01/2018
3	Adenosine Monophosphate (AMP)IBA 01/2020 - 05/2014
3	Cyclic AMP (AMP, Cyclic)IBA 01/2020 - 07/2016
3	AntioxidantsIBA 08/2018 - 07/2004
3	EnzymesIBA 01/2018 - 11/2007
3	LithiumIBA 07/2017 - 01/2013
2	Mutant Proteins (Protein, Mutant)IBA 02/2024 - 01/2017
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2024 - 12/2020
2	Neuroprotective AgentsIBA 12/2023 - 11/2020
2	GlobinsIBA 11/2023 - 01/2021
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2023 - 09/2021
2	CytidineIBA 06/2023 - 10/2021
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 01/2013
2	Lysine (L-Lysine)FDA Link 01/2023 - 01/2018
2	Streptozocin (Streptozotocin)FDA Link 01/2023 - 08/2018
2	Retinaldehyde (Retinal)IBA 01/2023 - 01/2020
2	AndrogensIBA 11/2022 - 02/2014
2	6-methyladenineIBA 10/2022 - 01/2022
2	Methotrexate (Mexate)FDA LinkGeneric 04/2022 - 01/2022
2	Indicators and Reagents (Reagents)IBA 03/2022 - 10/2019
2	CateninsIBA 01/2022 - 07/2016

Therapy/Procedure

17	Therapeutics 10/2023 - 01/2014
13	Drug Therapy (Chemotherapy) 10/2023 - 01/2013
4	Neoadjuvant Therapy 01/2020 - 10/2012
3	Ligation 01/2024 - 11/2016
2	Adjuvant Chemotherapy 02/2023 - 01/2013
2	Conservative Treatment 01/2023 - 09/2010
2	Length of Stay 04/2022 - 01/2022
2	Operative Time 04/2022 - 01/2022